BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16773321)

  • 1. [Cost-benefit analysis of the use of rhBMP-2 in open tibial fractures: savings from a health insurer's perspective].
    Alt V; Eicher A; Bitschnau A; Schnettler R
    Unfallchirurg; 2006 Jun; 109(6):463-70. PubMed ID: 16773321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A health economic analysis of the use of rhBMP-2 in Gustilo-Anderson grade III open tibial fractures for the UK, Germany, and France.
    Alt V; Donell ST; Chhabra A; Bentley A; Eicher A; Schnettler R
    Injury; 2009 Dec; 40(12):1269-75. PubMed ID: 19539926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic considerations for the use of recombinant human bone morphogenetic protein-2 in open tibial fractures in Europe: the German model.
    Alt V; Heissel A
    Curr Med Res Opin; 2006; 22 Suppl 1():S19-22. PubMed ID: 16882366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant human Bone Morphogenetic Protein-2 (rhBMP-2) in grade III open tibia fractures treated with unreamed nails-A clinical and health-economic analysis.
    Alt V; Borgman B; Eicher A; Heiss C; Kanakaris NK; Giannoudis PV; Song F
    Injury; 2015 Nov; 46(11):2267-72. PubMed ID: 26374949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies.
    Swiontkowski MF; Aro HT; Donell S; Esterhai JL; Goulet J; Jones A; Kregor PJ; Nordsletten L; Paiement G; Patel A
    J Bone Joint Surg Am; 2006 Jun; 88(6):1258-65. PubMed ID: 16757759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in the use of bone morphogenetic protein in orthopaedic trauma surgery.
    Nordsletten L
    Curr Med Res Opin; 2006; 22 Suppl 1():S13-7; S23. PubMed ID: 16882365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein (BMP) for fracture healing in adults.
    Garrison KR; Shemilt I; Donell S; Ryder JJ; Mugford M; Harvey I; Song F; Alt V
    Cochrane Database Syst Rev; 2010 Jun; 2010(6):CD006950. PubMed ID: 20556771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients.
    Govender S; Csimma C; Genant HK; Valentin-Opran A; Amit Y; Arbel R; Aro H; Atar D; Bishay M; Börner MG; Chiron P; Choong P; Cinats J; Courtenay B; Feibel R; Geulette B; Gravel C; Haas N; Raschke M; Hammacher E; van der Velde D; Hardy P; Holt M; Josten C; Ketterl RL; Lindeque B; Lob G; Mathevon H; McCoy G; Marsh D; Miller R; Munting E; Oevre S; Nordsletten L; Patel A; Pohl A; Rennie W; Reynders P; Rommens PM; Rondia J; Rossouw WC; Daneel PJ; Ruff S; Rüter A; Santavirta S; Schildhauer TA; Gekle C; Schnettler R; Segal D; Seiler H; Snowdowne RB; Stapert J; Taglang G; Verdonk R; Vogels L; Weckbach A; Wentzensen A; Wisniewski T;
    J Bone Joint Surg Am; 2002 Dec; 84(12):2123-34. PubMed ID: 12473698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human bone morphogenetic protein-2: a randomized trial in open tibial fractures treated with reamed nail fixation.
    Aro HT; Govender S; Patel AD; Hernigou P; Perera de Gregorio A; Popescu GI; Golden JD; Christensen J; Valentin A
    J Bone Joint Surg Am; 2011 May; 93(9):801-8. PubMed ID: 21454742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human BMP-2 for the treatment of open tibial fractures.
    Wei S; Cai X; Huang J; Xu F; Liu X; Wang Q
    Orthopedics; 2012 Jun; 35(6):e847-54. PubMed ID: 22691656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic proteins in orthopaedic trauma: recent clinical findings with human bone morphogenetic protein-2 (rhBMP-2).
    Patel AD
    Curr Med Res Opin; 2006; 22 Suppl 1():S1-5. PubMed ID: 16882363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of tibial nonunion treatment: A comparison between rhBMP-7 and autologous bone graft in two Italian centres.
    Giorgio Calori M; Capanna R; Colombo M; De Biase P; O'Sullivan C; Cartareggia V; Conti C
    Injury; 2013 Dec; 44(12):1871-9. PubMed ID: 24074829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic analysis of using rhBMP-2 for lumbar fusion in Germany, France and UK from a societal perspective.
    Alt V; Chhabra A; Franke J; Cuche M; Schnettler R; Le Huec JC
    Eur Spine J; 2009 Jun; 18(6):800-6. PubMed ID: 19301041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Health-economic considerations for the use of BMP-2 for spinal surgery in Germany].
    Alt V; Haas H; Rauschmann MA; Carstens C; Franke J; Eicher A; Bitschnau A; Schnettler R
    Z Orthop Ihre Grenzgeb; 2006; 144(6):577-82. PubMed ID: 17187331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human bone morphogenic protein-2 in fracture care.
    Jones AL
    J Orthop Trauma; 2005; 19(10 Suppl):S23-5. PubMed ID: 16479219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine investigation of rhBMP-2, autogenous bone graft, and rhBMP-2 with autogenous bone graft for the healing of a large segmental tibial defect.
    Boyce AS; Reveal G; Scheid DK; Kaehr DM; Maar D; Watts M; Stone MB
    J Orthop Trauma; 2009; 23(10):685-92. PubMed ID: 19858976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human bone morphogenetic protein-2 on fracture healing in a goat tibial fracture model.
    Welch RD; Jones AL; Bucholz RW; Reinert CM; Tjia JS; Pierce WA; Wozney JM; Li XJ
    J Bone Miner Res; 1998 Sep; 13(9):1483-90. PubMed ID: 9738522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial.
    Jones AL; Bucholz RW; Bosse MJ; Mirza SK; Lyon TR; Webb LX; Pollak AN; Golden JD; Valentin-Opran A;
    J Bone Joint Surg Am; 2006 Jul; 88(7):1431-41. PubMed ID: 16818967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of recombinant human bone morphogenetic protein-2/calcium phosphate matrix for closed tibial diaphyseal fracture: a double-blind, randomized, controlled phase-II/III trial.
    Lyon T; Scheele W; Bhandari M; Koval KJ; Sanchez EG; Christensen J; Valentin A; Huard F
    J Bone Joint Surg Am; 2013 Dec; 95(23):2088-96. PubMed ID: 24306695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone morphogenetic proteins in open fractures: past, present, and future.
    Nauth A; Ristiniemi J; McKee MD; Schemitsch EH
    Injury; 2009 Dec; 40 Suppl 3():S27-31. PubMed ID: 20082787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.